SCHEMBL14239265

SCHEMBL14239265

Nc1ccc(-n2cnc(C(=O)O)c2)nc1

nearest known ligand 0.51

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.51
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CPB2 Q96IY4 3/20 0.34
CHRM4 P08173 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2894504 0.81 KDM4E (0.54) KDM4EMEN1KMT2ACPB2
SCHEMBL9375743 0.81 KDM4E (0.51) KDM4EMEN1KMT2ACPB2
SCHEMBL27433676 0.79 KDM4E (0.48) KDM4E
SCHEMBL14167780 0.78 CHRM4 (0.51) KDM4ECHRM4
SCHEMBL9375535 0.78 MAPT (0.49) KDM4EMEN1KMT2A
SCHEMBL9372804 0.74 KDM4E (0.61) KDM4EMEN1KMT2ACPB2
SCHEMBL11901224 0.73 GRIN2D (0.36) KDM4E
SCHEMBL11962606 0.73 CYP2E1 (0.44)
SCHEMBL21623961 0.72 KDM4E (0.51) KDM4EMEN1KMT2A
SCHEMBL11899712 0.72 RAB9A (0.49) KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012168315-A1 SUBSTITUTED PIPERIDINES AS GPR119 MODULATORS FOR THE TREATMENT OF METABOLIC DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-12-13 WO disclosed